HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Drugstore.com Sales Jump Almost Seven-Fold To $24.6 Mil. In 2Q

This article was originally published in The Rose Sheet

Executive Summary

Amazon.com's "Health & Beauty" tab has generated more traffic for partner drugstore.com than any other source since the tab's inception in April, drugstore.com Chairman and CEO Peter Neupert announced during a conference call with securities analysts July 31.

You may also be interested in...



Drugstore.com Traffic Up 20%-30% Since Amazon.com Partnership

Drugstore.com's strategic partnership with Amazon.com has increased site traffic 20%-30% since the launch of the "Health & Beauty" tab linking the two sites, drugstore.com Chairman and CEO Peter Neupert reported in an April 24 call with securities analysts.

Drugstore.com

Health & Beauty tab on Amazon.com linking consumers to drugstore.com goes live April 17. The move follows the announcement of a strategic agreement between the two e-tailers under which Amazon owns nearly 28% of drugstore.com (1"The Rose Sheet" Jan. 31, p. 12). The new gateway provides Amazon's 17 mil. consumers with access to drugstore.com's more than 20,000 health and beauty care products

Drugstore.com Enters Prestige H&BA Market With Beauty.com Buy

Drugstore.com's proposed acquisition of beauty.com will provide the e-tailer with prestige-positioned H&BA offerings to complement its mass market brands. In a deal announced Jan. 12, drugstore.com will acquire beauty.com for approximately 1.3 mil. shares of stock worth about $42 mil.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS008280

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel